EXHIBITORS

American Brain Foundation

Booth 22 americanbrainfoundation.org/ngrg

Stop by the American Brain Foundation booth to purchase a t-shirt and other exclusive items, learn about grant opportunities for 2024, or make a donation to support the critical need for research funding. Founded by the American Academy of Neurology, the American Brain Foundation has been investing in research for improved prevention, treatment, and cures for neurologic diseases and disorders for over 30 years. Meet our current class of researchers at americanbrainfoundation.org/ngrg.

Access TeleCare

Booth 8 accesstelecare.com

We start with the medicine. We start with our physicians. With our network of more than 600 specialists and subspecialists from some of the nation’s most esteemed health care systems and academic medical centers, every hospital in every community can give its patients worldclass care. We facilitate that care with our technology. Our telemedicine carts are designed by physicians who understand how powerful technology can be but also how it can obstruct and frustrate if not done well. And, we support that care by working with hospitals to make it financially sustainable.

Alexion

Booth 5 alexion.com

Alexion is a global biopharmaceutical company with the mission of transforming the lives of people affected by rare diseases by continuously innovating and creating meaningful value in all that we do. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Altus Biologics

Booth 17 altusbiologics.com

About us, Altus Biologics, In-Office Biologic Therapy Management Solutions. Since 2010, Altus Biologics has been partnering with physicians to provide comprehensive infusion therapy services in their offices, ensuring the best standard of care at the point of service to patients. In-office infusion therapy allows patients to receive their treatment in a comfortable, convenient, and familiar environment under the supervision of their trusted healthcare team. Healthcare providers benefit from increased patient management, interaction, and education — all of which can strengthen the provider-patient relationship and patient outcomes.

Argenx

Booth 15 argenx.com argenx is a global immunology company developing antibody-based medicines for patients suffering from severe autoimmune diseases and cancer. By translating immunology breakthroughs into innovative drug candidates, argenx is building a world-class portfolio of first-in-class antibodies in both early and late clinical-stages of development.

Brain PAC/Advocacy

Booth 21 aan.com/advocacy/brainpac

BrainPAC is the political action committee (PAC) of the American Academy of Neurology, and the only federal political action committee in Washington, DC, that specifically represents the profession of neurology. It gives the AAN a strong voice on Capitol Hill and exists to support and help elect neurology-friendly candidates to the U.S. Congress. Personal contributions to BrainPAC help us advocate for AAN priorities. BrainPAC is a nonpartisan PAC and contributes to both Democrats and Republicans who support our issues.

Catalyst Pharmaceuticals

Booth 4 catalystpharma.com

With exceptional patient focus, Catalyst is committed to developing and commercializing innovative first-in-class medicines that address rare neurological and epileptic diseases. Catalyst’s U.S. commercial product portfolio consists of FIRDAPSE® (amifampridine) Tablets 10 mg, approved for the treatment of LambertEaton myasthenic syndrome (“LEMS”) for adults and children ages six to seventeen. In January 2023, Catalyst acquired the U.S. commercial rights of FYCOMPA® (perampanel) CIII, a prescription medicine approved in people with epilepsy aged four and older alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures, and with other medicines to treat primary generalized tonic-clonic seizures for people with epilepsy aged 12 and older. Further, Canada’s national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.

DiaMedica

Booth 1 diamedica.com

DiaMedica is in a pivotal Phase 2b/3 for DM199, a recombinant KLK1 protein, for the treatment of acute ischemic stroke. DM199 is believed to improve collateral circulation in the ischemic penumbra.

Genentech

Booth 6 gene.com

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or lifethreatening medical conditions. Today, we are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.

Horizon Therapeutics

Booth 7

Booth 9 camc.org horizontherapeutics.com

CAMC is a nonprofit, 1,103-bed regional referral center made up of six hospitals: CAMC General Hospital, CAMC Greenbrier Valley Medical Center, CAMC Memorial Hospital, CAMC Plateau Medical Center, CAMC Teays Valley Hospital and CAMC Women and Children’s Hospital, as well as the CAMC Institute for Academic Medicine and the CAMC Foundation. Nearly 900 physicians have admitting privileges at CAMC, which is also West Virginia’s premiere medical teaching facility, hosting, on any given day, more than 800 students in programs leading to degrees or certifications in health professions. CAMC started a Neurology Residency Program July 1, 2023.

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.